<DOC>
	<DOC>NCT01181141</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective hip fracture surgery.</brief_summary>
	<brief_title>Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Subjects who are scheduled to undergo surgery within 10 days for fracture of inner or outer femoral neck (trochanteric and subtrochanteric) Subjects with risks of hemorrhage Subjects with thrombolic risks Subjects who weigh less than 40 kg Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Anticoagulants</keyword>
	<keyword>Enoxaparin sodium</keyword>
	<keyword>venous thromboembolism.</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>deep vein thrombosis</keyword>
	<keyword>DU-176b</keyword>
	<keyword>Edoxaban</keyword>
	<keyword>factor Xa</keyword>
	<keyword>hip fracture surgery</keyword>
	<keyword>embolism</keyword>
</DOC>